B. Riley Wealth Advisors, Inc. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 166 filers reported holding CARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$93,489
-78.7%
55,648
-64.1%
0.00%
-70.0%
Q2 2023$438,622
+83.6%
154,990
+218.6%
0.01%
+66.7%
Q1 2023$238,862
-51.8%
48,648
+5.4%
0.01%
-57.1%
Q4 2022$495,630
+19.7%
46,148
+4.5%
0.01%
+7.7%
Q3 2022$414,00044,1700.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders